Voyager Therapeutics VYGR
NASDAQ VYGR
$2.68 +0.04 (+1.52%)
At close: Sep 30, 2026 · 4:00 PM EDT

Voyager Therapeutics (VYGR) Current Deferred Revenue (2015 - 2026)

Updated

Voyager Therapeutics (VYGR) reported Current Deferred Revenue of $244,000 for Q2 2026, down 98.8% from $20.52 million a year earlier and down 38.2% from the prior quarter.

Analysis

Voyager Therapeutics (VYGR) Current Deferred Revenue (2015 - 2026) Analysis & Trends

At the end of FY2025, Voyager Therapeutics posted Current Deferred Revenue of $1.59 million, down 93.5% from FY2024.

  • Current Deferred Revenue has declined for three consecutive years, with a five-year compound annual growth rate of -27.1% (FY2020 to FY2025).
  • By year, Current Deferred Revenue came in at $24.39 million in FY2024 (-43.1%), $42.88 million in FY2023 (-27.8%), $59.38 million in FY2022 (+75.2%) and $33.89 million in FY2021 (+338.4%).
  • The Q2 2026 figure ranks as the lowest quarterly Current Deferred Revenue in data going back to Q3 2015.
  • Year over year, Current Deferred Revenue has now declined in each of the last four quarters, with an average decline of 61.8% over the last eight quarters.
  • The high point for year-over-year Current Deferred Revenue in five years was Q2 2022 (growth of 978.2%); the low point was Q2 2026 (a decline of 98.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $395,000 (Q1 2026), $1.59 million (Q4 2025) and $10.58 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Voyager Therapeutics 161.76 Mn -501.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 244,000.00
Mar 31, 2026 395,000.00
Dec 31, 2025 1.59 Mn
Sep 30, 2025 10.58 Mn
Jun 30, 2025 20.52 Mn
Mar 31, 2025 21.10 Mn
Dec 31, 2024 24.39 Mn
Sep 30, 2024 22.63 Mn
Jun 30, 2024 20.52 Mn
Mar 31, 2024 51.44 Mn
Dec 31, 2023 42.88 Mn
Sep 30, 2023 44.26 Mn
Jun 30, 2023 31.67 Mn
Mar 31, 2023 5.68 Mn
Dec 31, 2022 59.38 Mn
Sep 30, 2022 56.63 Mn
Jun 30, 2022 87.00 Mn
Mar 31, 2022 86.99 Mn
Dec 31, 2021 33.89 Mn
Sep 30, 2021 9.54 Mn
API Access

Voyager Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VYGR&period=max&api_key=YOUR_API_KEY